The relative proportions of secreted interleukin-2 and interleukin-10 determine the magnitude of rheumatoid arthritis T-cell proliferation to the recall antigen tuberculin purified protein derivative

被引:10
作者
Corrigall, VM
Garyfallos, A
Panayi, GS
机构
[1] Univ London Kings Coll, Guys Kings & St Thomas Sch Med, Dept Rheumatol, London SE1 9RT, England
[2] Aristotelian Univ Salonika, Hippokrat Gen Hosp, Dept Med 4, GR-54006 Salonika, Greece
关键词
T lymphocyte; IL-2; IL-10; recall antigens;
D O I
10.1093/rheumatology/38.12.1203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate the mechanisms of the deficient proliferative responses by rheumatoid arthritis (RA) peripheral blood T cells to the recall antigen tuberculin purified protein derivative (PPD). Methods. The concomitant production of interleukin (IL)-2, IL-10 and lymphocyte proliferation were studied by enzyme-linked immunosorbent assay and [H-3]thymidine uptake, respectively, in 12 normal controls and eight RA patients. Results. An inverse correlation was found between IL-10 production and proliferation to PPD. The proliferative response was shown to be critically affected by the IL-2:IL-10 ratio so that absolute levels of secreted IL-2 or IL-10 correlated non-significantly with lymphocyte proliferation. Conclusion. The deficient T-cell proliferation in RA peripheral blood mononuclear cells is related to the relative proportions of IL-2:IL-10 rather than the absolute amounts secreted.
引用
收藏
页码:1203 / 1207
页数:5
相关论文
共 16 条
  • [1] SERUM IL-4, IL-10 AND IL-6 LEVELS IN INFLAMMATORY ARTHRITIS
    CICUTTINI, FM
    BYRON, KA
    MAHER, D
    WOOTTON, AM
    MUIRDEN, KD
    HAMILTON, JA
    [J]. RHEUMATOLOGY INTERNATIONAL, 1995, 14 (05) : 201 - 206
  • [2] Coakley G, 1998, BRIT J RHEUMATOL, V37, P988
  • [3] CHRONIC EXPOSURE TO TUMOR-NECROSIS-FACTOR (TNF) IN-VITRO IMPAIRS THE ACTIVATION OF T-CELLS THROUGH THE T-CELL RECEPTOR CD3 COMPLEX - REVERSAL IN-VIVO BY ANTI-TNF ANTIBODIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    COPE, AP
    LONDEI, M
    CHU, NR
    COHEN, SBA
    ELLIOTT, MJ
    BRENNAN, FM
    MAINI, RN
    FELDMANN, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) : 749 - 760
  • [4] ELEVATED INTERLEUKIN-10 LEVELS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    CUSH, JJ
    SPLAWSKI, JB
    THOMAS, R
    MCFARLIN, JE
    SCHULZEKOOPS, H
    DAVIS, LS
    FUJITA, K
    LIPSKY, PE
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (01): : 96 - 104
  • [5] EMERY P, 1984, CLIN EXP IMMUNOL, V57, P123
  • [6] KEIJERS V, 1997, ARTHRITIS RHEUM
  • [7] KINGSLEY GH, 1987, J RHEUMATOL, V14, P667
  • [8] CIRCULATING INTERLEUKIN-10 AND INTERLEUKIN-6 SERUM LEVELS IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH METHOTREXATE OR GOLD SALTS - PRELIMINARY-REPORT
    LACKI, JK
    KLAMA, K
    MACKIEWICZ, SH
    MACKIEWICZ, U
    MULLER, W
    [J]. INFLAMMATION RESEARCH, 1995, 44 (01) : 24 - 26
  • [9] LAPADULA G, 1995, CLIN EXP RHEUMATOL, V13, P629
  • [10] MALEFYT RD, 1991, J EXP MED, V174, P915